Implantable cardioverter‐defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation

Introduction Tricuspid regurgitation is associated with significant morbidity and mortality, and occurs at a higher rate in patients with cardiovascular implantable electronic devices. Percutaneous strategies for managing tricuspid regurgitation are evolving, including the development of bicaval valve implantation which has been successfully used in patients with pacing leads. Methods and Results We present the first documented case of lead failure following TricValve® implantation, a dedicated self‐expanding system for bicaval valve implantation, and the first successful lead revision procedure in this setting. Conclusion The case illustrates important considerations in undertaking percutaneous intervention in patients with cardiovascular implantable electronic devices, and their ongoing management.